Effect of interleukin-6 receptor inhibition with tocilizumab in patients with rheumatoid arthritis (OPTION study): a double-blind, placebo-controlled, randomised trial.
Saved in:
| Title: | Effect of interleukin-6 receptor inhibition with tocilizumab in patients with rheumatoid arthritis (OPTION study): a double-blind, placebo-controlled, randomised trial. |
|---|---|
| Authors: | Beaulieu, Andre, Rubbert-Roth, Andrea, Ramos-Remus, Cesar, Rovensky, Josef, Alecock, Emma, Woodworth, Thasia, Alten, Rieke, Smolen, Josef S. |
| Source: | Lancet. 3/22/2008, Vol. 371 Issue 9617, p987-997. 11p. |
| Subjects: | Rheumatoid arthritis, Autoimmune diseases, Arthritis patients, Drug efficacy, Interleukin-6, Interleukins, Patients |
| Abstract: | The article focuses on research on rheumatoid arthritis which was done in an effort to assess the therapeutic effects of blocking interleukin 6 with the inhibition of the interleukin 6 receptor with tocilizumab in patients with rheumatoid arthritis. Researchers used a double blind, randomised, placebo controlled study which looked at 623 arthritis patients. They found that patients receiving tocilizumab had improvement in swollen and tender joints. They concluded that tocilizumab could be an effective therapeutic approach in patients with moderate to severe arthritis. |
| Database: | Psychology and Behavioral Sciences Collection |
| FullText | Text: Availability: 0 |
|---|---|
| Header | DbId: pbh DbLabel: Psychology and Behavioral Sciences Collection An: 31413232 AccessLevel: 6 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Effect of interleukin-6 receptor inhibition with tocilizumab in patients with rheumatoid arthritis (OPTION study): a double-blind, placebo-controlled, randomised trial. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AR" term="%22Beaulieu%2C+Andre%22">Beaulieu, Andre</searchLink><br /><searchLink fieldCode="AR" term="%22Rubbert-Roth%2C+Andrea%22">Rubbert-Roth, Andrea</searchLink><br /><searchLink fieldCode="AR" term="%22Ramos-Remus%2C+Cesar%22">Ramos-Remus, Cesar</searchLink><br /><searchLink fieldCode="AR" term="%22Rovensky%2C+Josef%22">Rovensky, Josef</searchLink><br /><searchLink fieldCode="AR" term="%22Alecock%2C+Emma%22">Alecock, Emma</searchLink><br /><searchLink fieldCode="AR" term="%22Woodworth%2C+Thasia%22">Woodworth, Thasia</searchLink><br /><searchLink fieldCode="AR" term="%22Alten%2C+Rieke%22">Alten, Rieke</searchLink><br /><searchLink fieldCode="AR" term="%22Smolen%2C+Josef+S%2E%22">Smolen, Josef S.</searchLink> – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22Lancet%22">Lancet</searchLink>. 3/22/2008, Vol. 371 Issue 9617, p987-997. 11p. – Name: Subject Label: Subjects Group: Su Data: <searchLink fieldCode="DE" term="%22Rheumatoid+arthritis%22">Rheumatoid arthritis</searchLink><br /><searchLink fieldCode="DE" term="%22Autoimmune+diseases%22">Autoimmune diseases</searchLink><br /><searchLink fieldCode="DE" term="%22Arthritis+patients%22">Arthritis patients</searchLink><br /><searchLink fieldCode="DE" term="%22Drug+efficacy%22">Drug efficacy</searchLink><br /><searchLink fieldCode="DE" term="%22Interleukin-6%22">Interleukin-6</searchLink><br /><searchLink fieldCode="DE" term="%22Interleukins%22">Interleukins</searchLink><br /><searchLink fieldCode="DE" term="%22Patients%22">Patients</searchLink> – Name: Abstract Label: Abstract Group: Ab Data: The article focuses on research on rheumatoid arthritis which was done in an effort to assess the therapeutic effects of blocking interleukin 6 with the inhibition of the interleukin 6 receptor with tocilizumab in patients with rheumatoid arthritis. Researchers used a double blind, randomised, placebo controlled study which looked at 623 arthritis patients. They found that patients receiving tocilizumab had improvement in swollen and tender joints. They concluded that tocilizumab could be an effective therapeutic approach in patients with moderate to severe arthritis. |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=pbh&AN=31413232 |
| RecordInfo | BibRecord: BibEntity: Languages: – Code: eng Text: English PhysicalDescription: Pagination: PageCount: 11 StartPage: 987 Subjects: – SubjectFull: Rheumatoid arthritis Type: general – SubjectFull: Autoimmune diseases Type: general – SubjectFull: Arthritis patients Type: general – SubjectFull: Drug efficacy Type: general – SubjectFull: Interleukin-6 Type: general – SubjectFull: Interleukins Type: general – SubjectFull: Patients Type: general Titles: – TitleFull: Effect of interleukin-6 receptor inhibition with tocilizumab in patients with rheumatoid arthritis (OPTION study): a double-blind, placebo-controlled, randomised trial. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Beaulieu, Andre – PersonEntity: Name: NameFull: Rubbert-Roth, Andrea – PersonEntity: Name: NameFull: Ramos-Remus, Cesar – PersonEntity: Name: NameFull: Rovensky, Josef – PersonEntity: Name: NameFull: Alecock, Emma – PersonEntity: Name: NameFull: Woodworth, Thasia – PersonEntity: Name: NameFull: Alten, Rieke – PersonEntity: Name: NameFull: Smolen, Josef S. IsPartOfRelationships: – BibEntity: Dates: – D: 22 M: 03 Text: 3/22/2008 Type: published Y: 2008 Identifiers: – Type: issn-print Value: 01406736 Numbering: – Type: volume Value: 371 – Type: issue Value: 9617 Titles: – TitleFull: Lancet Type: main |
| ResultId | 1 |